Sign Out
Non-Small Cell Lung Cancer: TARLONIB is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
Pancreatic Cancer: TARLONIB in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
Continue with Google